Literature DB >> 10898597

Phosphobutyrylcholinesterase: phosphorylation of the esteratic site of butyrylcholinesterase by ethephon [(2-chloroethyl)phosphonic acid] dianion.

J E Haux1, G B Quistad, J E Casida.   

Abstract

Ethephon [(2-chloroethyl)phosphonic acid] has two seemingly unrelated types of biological activity. It is a major agrochemical absorbed by crops, slowly releasing ethylene as a plant growth regulator. Ethephon also inhibits the activity of plasma butyrylcholinesterase (BuChE) in humans, dogs, rats, and mice. This is totally unexpected for an ionized phosphonic acid (mostly the dianion at physiological pH), in contrast to the classical inhibitors (nonionized triester phosphates) which phosphorylate serine at the active site. This study tests the hypothesis that ethephon (as the dianion) also acts as a phosphorylating agent in inhibiting BuChE activity. The sensitivity of plasma BuChE to ethephon (90 min preincubation at 25 degrees C) is greatest for humans, dogs, and mice (IC(50) = 6-23 microM), intermediate for chickens, rabbits, rats, and guinea pigs (IC(50) = 26-53 microM), and lowest for pigs and horses (IC(50) = 92-172 microM). The IC(50) decreases linearly with time on a log-log scale to values of 0.15-0. 3 microM for human, dog, and horse BuChE at 24 h. The inhibition rate is generally related to ethephon concentration, consistent with a bimolecular reaction, e.g., phosphorylation. The extent of inhibition of the esteratic activity of BuChE by ethephon is directly proportional to the extent of inhibition of [(3)H]diisopropyl phosphorofluoridate ([(3)H]DFP) postlabeling which is not reversible on removing the ethephon, either directly or after further incubation for 24 h at 25 degrees C. These observations strongly suggest that ethephon, as DFP, phosphorylates human plasma BuChE at Ser-198 of the esteratic site, or more generally, the formation of a phosphobutyrylcholinesterase. With human plasma BuChE, (2-bromoethyl)- and (2-iodoethyl)phosphonic acids have lower affinities for the site than ethephon but higher phosphorylation rate constants, consistent with their relative hydrolysis rates at pH 7.4 (phosphorylation of water). (2-Chlorohexyl)phosphonic acid is a poor inhibitor, perhaps being too reactive with water. Thus, potency differences for ethephon and its analogues with BuChE of various species depend on both the affinities and phosphorylation rates, i.e., the binding and reactivity of the (2-haloalkyl)phosphonic acid dianion in the esteratic site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898597     DOI: 10.1021/tx000027w

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

1.  Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity.

Authors:  M Biffen; H Matsui; S Edwards; A J Leishman; K Eiho; E Holness; G Satterthwaite; I Doyle; H Wada; N J Fraser; S L Hawkins; M Aoki; H Tomizawa; A D Benjamin; H Takaku; T McInally; C M Murray
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Investigation of in vitro effects of ethephon and chlorpyrifos, either alone or in combination, on rat intestinal muscle contraction.

Authors:  Mustafa Alp Cetinkaya; Emine Baydan
Journal:  Interdiscip Toxicol       Date:  2010-03-29

3.  Ethephon, an organophosphorous, a Fruit and Vegetable Ripener: Has potential hepatotoxic effects?

Authors:  Pooja Bhadoria; Mahindra Nagar; Veena Bharihoke; Ajeet Singh Bhadoria
Journal:  J Family Med Prim Care       Date:  2018 Jan-Feb

4.  Characterization of the transient oxaphosphetane BChE inhibitor formed from spontaneously activated ethephon.

Authors:  Stephen R Lantz; John E Casida
Journal:  Chem Res Toxicol       Date:  2013-08-13       Impact factor: 3.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.